Pages that link to "Q45889196"
Jump to navigation
Jump to search
The following pages link to Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs (Q45889196):
Displaying 50 items.
- Nanoparticulate carriers for the treatment of coronary restenosis (Q28220309) (← links)
- Mechanism of eNOS gene transfer inhibition of vascular smooth muscle cell proliferation (Q28579176) (← links)
- Improved adenovirus vectors for infection of cardiovascular tissues (Q30657410) (← links)
- Photoactivation of vascular iNOS and elevation of cGMP in vivo: possible mechanism for photovasorelaxation and inhibition of restenosis in an atherosclerotic rabbit models. (Q30658999) (← links)
- Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease (Q30830095) (← links)
- Restenosis: a challenge for pharmacology (Q30882943) (← links)
- Gene therapy and vascular disease (Q33637644) (← links)
- Platelets and restenosis (Q33862443) (← links)
- Gene therapy for peripheral arterial disease. (Q33946210) (← links)
- Nitric oxide (NO)-related pharmaceuticals: contemporary approaches to therapeutic NO modulation (Q33991778) (← links)
- Endothelial cell delivery for cardiovascular therapy (Q34003157) (← links)
- Antithrombotic strategies in gene therapy (Q34027383) (← links)
- Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential (Q34105472) (← links)
- Non-viral eNOS gene delivery and transfection with stents for the treatment of restenosis (Q34203043) (← links)
- Local gene delivery to the vessel wall (Q34418987) (← links)
- LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity (Q34435119) (← links)
- Gene transfer to the vasculature: historical perspective and implication for future research objectives (Q34982950) (← links)
- Molecular approaches for the treatment of atherosclerosis (Q35020341) (← links)
- Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis (Q35027751) (← links)
- Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries (Q35054188) (← links)
- Applied gene therapy in preclinical models of vascular injury (Q35095408) (← links)
- New strategies to prevent restenosis (Q35631356) (← links)
- Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells (Q35740400) (← links)
- Cardiovascular gene therapy: current status and therapeutic potential. (Q35995220) (← links)
- Gene therapy for the extension of vein graft patency: a review (Q36032833) (← links)
- Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. (Q36327570) (← links)
- High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents (Q36392994) (← links)
- Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk (Q36469473) (← links)
- Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia (Q36497132) (← links)
- Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury (Q36661502) (← links)
- Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention (Q36684479) (← links)
- Current status of cardiovascular gene therapy (Q36823697) (← links)
- Hydrogen sulphide and its therapeutic potential (Q36975742) (← links)
- Plasma ADMA predicts restenosis of arteriovenous fistula. (Q37042201) (← links)
- Designing heart performance by gene transfer. (Q37299072) (← links)
- Gender-specific modulation of the response to arterial injury by soluble guanylate cyclase α1. (Q37346565) (← links)
- Nitric oxide synthase gene therapy: progress and prospects. (Q37492606) (← links)
- Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis (Q37511128) (← links)
- Efficient transduction of primary vascular cells by the rare adenovirus serotype 49 vector (Q38901143) (← links)
- Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine (Q39434479) (← links)
- Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery (Q40159712) (← links)
- Cyclic guanosine monophosphate-dependent protein kinase I promotes adhesion of primary vascular smooth muscle cells. (Q41774906) (← links)
- Role of smooth muscle cGMP/cGKI signaling in murine vascular restenosis (Q41865010) (← links)
- Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury (Q43459170) (← links)
- Adenovirus-mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty. (Q43851404) (← links)
- P1,P4-diadenosine 5'-tetraphosphate induced DNA synthesis in mechanically injured cultured endothelial cells (Q44309686) (← links)
- Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice (Q45172377) (← links)
- Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo (Q45866216) (← links)
- Gene therapy for atherosclerosis and atherosclerosis-related diseases (Q45873371) (← links)
- Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model (Q56944425) (← links)